{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:00:26Z","timestamp":1790200826660,"version":"4.1.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Urea cycle disorders (UCD) are inborn errors of metabolism caused by deficiency of enzymes required to convert nitrogen from ammonia into urea. Current paradigms of treatment focus on dietary manipulations, ammonia scavenger drugs, and liver transplantation. The aim of this study was to describe the characteristics and indication of liver transplantation in UCD in a tertiary hospital. We performed a retrospective study of children with UCD seen in the period 2000\u20132021. Data was collected on clinical onset, hyperammonemia severity, evolution and liver transplantation. There were 33 patients in the study period, whose diagnosis were: ornithine transcarbamylase (OTC, <jats:italic>n<\/jats:italic>\u2009=\u200920, 10 females), argininosuccinate synthetase (ASS, <jats:italic>n<\/jats:italic>\u2009=\u20096), carbamylphosphate synthetase 1 (CPS1, <jats:italic>n<\/jats:italic>\u2009=\u20094), argininosuccinate lyase (ASL, <jats:italic>n<\/jats:italic>\u2009=\u20092) and N-acetylglutamate synthetase (NAGS, <jats:italic>n<\/jats:italic>\u2009=\u20091) deficiency. Thirty one were detected because of clinical symptoms (45% with neonatal onset). The other 2 were diagnosed being presymptomatic, by neonatal\/family screening. Neonatal forms (<jats:italic>n<\/jats:italic>\u2009=\u200914) were more severe, all of them presented during the first week of life as severe hyperammonemia (mean peak 1,152\u2005\u00b5mol\/L). Seven patients died (6 at debut) and all survivors received transplantation. There was no mortality among the late forms. Of the 27 patients who did not die in the neonatal period, 16 (59%) received liver transplantationwith 100% survival, normal protein tolerance and usual need of citrulline supplementation. The transplant's metabolic success was accompanied by neurologic sequelae in 69%, but there was no progression of brain damage. Decision of continuous medical treatment in 11 patients appeared to be related with preserved neurodevelopment and fewer metabolic crises.<\/jats:p>","DOI":"10.3389\/fped.2023.1103757","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T04:57:27Z","timestamp":1677819447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Urea cycle disorders and indications for liver transplantation"],"prefix":"10.3389","volume":"11","author":[{"given":"Marta","family":"Garc\u00eda Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 D.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Frauca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Mu\u00f1oz Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda D.","family":"Lled\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bergua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Hierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10545-011-9427-0","article-title":"Long-term outcome and intervention of urea cycle disorders in Japan","volume":"35","author":"Kido","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/lt.23765","article-title":"Pediatric liver transplantation for urea cycle disorders and organic acidemias: united network for organ sharing data for 2002\u20132012","volume":"20","author":"Perito","year":"2014","journal-title":"Liver Transpl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jimd.12209","article-title":"Choosing between medical management and liver transplant in urea cycle disorders: a conceptual framework for parental treatment decision-making in rare disease","volume":"43","author":"Gerstein","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e13191","DOI":"10.1111\/petr.13191","article-title":"Liver transplantation for neonatal onset citrullinemia","volume":"22","author":"Vara","year":"2018","journal-title":"Pediatr Transpl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ymgme.2020.10.013","article-title":"Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders","volume":"131","author":"Posset","year":"2020","journal-title":"Mol Genet Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/lt.25433","article-title":"Evolving trends in liver transplant for metabolic liver disease in the United States","volume":"25","author":"McKiernan","year":"2019","journal-title":"Liver Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ymgmr.2016.07.003","article-title":"Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patient, caregiver, and provider perspectives","volume":"8","author":"Shchelochkov","year":"2016","journal-title":"Mol Genet Metab Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e12848","DOI":"10.1111\/petr.12848","article-title":"Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors","volume":"21","author":"Rahayatri","year":"2017","journal-title":"Pediatric Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2022057424","DOI":"10.1542\/peds.2022-057424","article-title":"Prognosis of children undergoing liver transplantation: a 30-year European study","volume":"150","author":"Baumann","year":"2022","journal-title":"Pediatrics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jimd.12318","article-title":"Liver and\/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: an overview on European data","volume":"44","author":"Molema","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.ymgme.2010.02.012","article-title":"Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study","volume":"100","author":"Campeau","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/BF01797930","article-title":"Treatment of inherited metabolic disorders by liver transplantation","volume":"14","author":"Burdelski","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.3748\/wjg.v21.i13.4063","article-title":"Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review","volume":"21","author":"Foschi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"Members of the urea cycle disorders consortium. A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol Genet Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/petr.12041","article-title":"Liver transplantation for urea cycle disorders in pediatric patients: a single-center experience","volume":"17","author":"Kim","year":"2013","journal-title":"Pediatr Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.25492","article-title":"Impact of diagnosis and therapy on cognitive function in urea cycle disorders","volume":"86","author":"Posset","year":"2019","journal-title":"Ann Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ymgme.2013.01.006","article-title":"Histopathological findings in livers of patients with urea cycle disorders","volume":"108","author":"Yaplito-Lee","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B20","first-page":"136","article-title":"Severe liver fibrosis in argininosuccinic aciduria","volume":"110","author":"Zimmermann","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF01811681","article-title":"Arginine remains an essential amino acid after liver transplantation in urea cycle enzyme deficiencies","volume":"14","author":"Rabier","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.ymgme.2003.08.027","article-title":"The role of liver transplantation in urea cycle disorders","volume":"81","author":"Leonard","year":"2004","journal-title":"Mol Genet Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4254\/wjh.v13.i10.1351","article-title":"Liver transplantation for pediatric inherited metabolic liver diseases","volume":"13","author":"Vimalesvaran","year":"2021","journal-title":"World J Hepatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1103757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T04:57:30Z","timestamp":1677819450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1103757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":23,"alternative-id":["10.3389\/fped.2023.1103757"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1103757","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1103757"}}